Stay updated on Pembrolizumab in mCRPC Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in mCRPC Clinical Trial page.

Latest updates to the Pembrolizumab in mCRPC Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedRevision updated from v3.3.1 to v3.3.2.SummaryDifference0.1%

- Check21 days agoChange DetectedThe page now displays Revision: v3.3.1, replacing Revision: v3.2.0. This update seems to be a technical version change with no impact on the study details or user-facing content.SummaryDifference0.1%

- Check29 days agoChange DetectedRemoved the government funding status notice that advised on open operations and where to check updates. The change does not affect trial details or outcomes.SummaryDifference0.4%

- Check43 days agoChange DetectedOnly visual formatting changes are visible; core study content such as title, eligibility criteria, endpoints, and results appears unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check71 days agoChange DetectedMajor update: page now includes a government funding status notice and indicates version 3.2.0, replacing the previous 3.1.0.SummaryDifference2%

- Check79 days agoChange DetectedUpdate: version bumped from v3.0.2 to v3.1.0; page now reflects the newer revision (v3.1.0).SummaryDifference0.0%

Stay in the know with updates to Pembrolizumab in mCRPC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in mCRPC Clinical Trial page.